209 related articles for article (PubMed ID: 22723466)
21. Clinical features and cancer risk in families with pathogenic
Xicola RM; Li S; Rodriguez N; Reinecke P; Karam R; Speare V; Black MH; LaDuca H; Llor X
J Med Genet; 2019 Dec; 56(12):838-843. PubMed ID: 31296550
[TBL] [Abstract][Full Text] [Related]
22. Identification of c.1531C>T Pathogenic Variant in the
Norero E; Alarcon MA; Hakkaart C; de Mayo T; Mellado C; Garrido M; Aguayo G; Lagos M; Torres J; Calvo A; Guilford P; Corvalan AH
Int J Mol Sci; 2019 Oct; 20(20):. PubMed ID: 31600923
[TBL] [Abstract][Full Text] [Related]
23. [Familial gastric cancer: diagnosis, treatment and periodic surveillance].
Kluijt I; Sijmons RH; Hoogerbrugge N; Vasen HF; Cats A
Ned Tijdschr Geneeskd; 2011; 155():A2731. PubMed ID: 21329544
[TBL] [Abstract][Full Text] [Related]
24. Early gastric cancer in young, asymptomatic carriers of germ-line E-cadherin mutations.
Huntsman DG; Carneiro F; Lewis FR; MacLeod PM; Hayashi A; Monaghan KG; Maung R; Seruca R; Jackson CE; Caldas C
N Engl J Med; 2001 Jun; 344(25):1904-9. PubMed ID: 11419427
[TBL] [Abstract][Full Text] [Related]
25. Periodic acid-schiff is superior to hematoxylin and eosin for screening prophylactic gastrectomies from CDH1 mutation carriers.
Lee AF; Rees H; Owen DA; Huntsman DG
Am J Surg Pathol; 2010 Jul; 34(7):1007-13. PubMed ID: 20534996
[TBL] [Abstract][Full Text] [Related]
26. Hereditary diffuse gastric cancer: prophylactic surgical oncology implications.
Lynch HT; Silva E; Wirtzfeld D; Hebbard P; Lynch J; Huntsman DG
Surg Clin North Am; 2008 Aug; 88(4):759-78, vi-vii. PubMed ID: 18672140
[TBL] [Abstract][Full Text] [Related]
27. Germline E-cadherin mutations in hereditary diffuse gastric cancer: assessment of 42 new families and review of genetic screening criteria.
Brooks-Wilson AR; Kaurah P; Suriano G; Leach S; Senz J; Grehan N; Butterfield YS; Jeyes J; Schinas J; Bacani J; Kelsey M; Ferreira P; MacGillivray B; MacLeod P; Micek M; Ford J; Foulkes W; Australie K; Greenberg C; LaPointe M; Gilpin C; Nikkel S; Gilchrist D; Hughes R; Jackson CE; Monaghan KG; Oliveira MJ; Seruca R; Gallinger S; Caldas C; Huntsman D
J Med Genet; 2004 Jul; 41(7):508-17. PubMed ID: 15235021
[TBL] [Abstract][Full Text] [Related]
28. An investigation of the factors effecting high-risk individuals' decision-making about prophylactic total gastrectomy and surveillance for hereditary diffuse gastric cancer (HDGC).
Hallowell N; Badger S; Richardson S; Caldas C; Hardwick RH; Fitzgerald RC; Lawton J
Fam Cancer; 2016 Oct; 15(4):665-76. PubMed ID: 27256430
[TBL] [Abstract][Full Text] [Related]
29. Prophylactic total gastrectomy (PTG) for hereditary diffuse gastric cancer (HDGC): the Newfoundland experience with 23 patients.
Hebbard PC; Macmillan A; Huntsman D; Kaurah P; Carneiro F; Wen X; Kwan A; Boone D; Bursey F; Green J; Fernandez B; Fontaine D; Wirtzfeld DA
Ann Surg Oncol; 2009 Jul; 16(7):1890-5. PubMed ID: 19408054
[TBL] [Abstract][Full Text] [Related]
30. Clinical implications of E-cadherin associated hereditary diffuse gastric cancer.
Fitzgerald RC; Caldas C
Gut; 2004 Jun; 53(6):775-8. PubMed ID: 15138199
[TBL] [Abstract][Full Text] [Related]
31. Hereditary gastric cancer.
Oliveira C; Seruca R; Carneiro F
Best Pract Res Clin Gastroenterol; 2009; 23(2):147-57. PubMed ID: 19414142
[TBL] [Abstract][Full Text] [Related]
32. [From gene to disease; E-cadherin and hereditary diffuse gastric cancer].
de Bruin JH; Ligtenberg MJ; Nagengast FM; van Krieken JH
Ned Tijdschr Geneeskd; 2003 Dec; 147(50):2474-7. PubMed ID: 14708213
[TBL] [Abstract][Full Text] [Related]
33. Unique challenges of risk-reducing surgery for hereditary diffuse gastric cancer syndrome: a narrative review.
Gallanis AF; Davis JL
Eur J Cancer Prev; 2023 Jul; 32(4):391-395. PubMed ID: 36977191
[TBL] [Abstract][Full Text] [Related]
34. Prophylactic total gastrectomy in hereditary diffuse gastric cancer: identification of two novel CDH1 gene mutations-a clinical observational study.
Bardram L; Hansen TV; Gerdes AM; Timshel S; Friis-Hansen L; Federspiel B
Fam Cancer; 2014 Jun; 13(2):231-42. PubMed ID: 24389957
[TBL] [Abstract][Full Text] [Related]
35. Hereditary diffuse gastric cancer: translation of CDH1 germline mutations into clinical practice.
Guilford P; Humar B; Blair V
Gastric Cancer; 2010 Mar; 13(1):1-10. PubMed ID: 20373070
[TBL] [Abstract][Full Text] [Related]
36. Hereditary diffuse gastric cancer (HDGC). An overview.
Taja-Chayeb L; Vidal-Millán S; Trejo-Becerril C; Pérez-Cárdenas E; Chávez-Blanco A; Domínguez-Gómez G; González-Fierro A; Romo-Pérez A; Dueñas-González A
Clin Res Hepatol Gastroenterol; 2022 Apr; 46(4):101820. PubMed ID: 34656755
[TBL] [Abstract][Full Text] [Related]
37. Familial gastric cancer: guidelines for diagnosis, treatment and periodic surveillance.
Kluijt I; Sijmons RH; Hoogerbrugge N; Plukker JT; de Jong D; van Krieken JH; van Hillegersberg R; Ligtenberg M; Bleiker E; Cats A;
Fam Cancer; 2012 Sep; 11(3):363-9. PubMed ID: 22388873
[TBL] [Abstract][Full Text] [Related]
38. [Hereditary diffuse gastric cancer].
Sezeur A; Schielke A; Larue L; Fléjou JF
Gastroenterol Clin Biol; 2006 Oct; 30(10):1205-13. PubMed ID: 17075480
[TBL] [Abstract][Full Text] [Related]
39. Germline mutation of the E-cadherin gene in three sibling cases with advanced gastric cancer: clinical consequences for the other family members.
Mayrbaeurl B; Keller G; Schauer W; Burgstaller S; Czompo M; Hoebling W; Knoflach P; Duba HC; Hoefler H; Thaler J
Eur J Gastroenterol Hepatol; 2010 Mar; 22(3):306-10. PubMed ID: 19474748
[TBL] [Abstract][Full Text] [Related]
40. A novel truncating mutation in the E-cadherin gene in the first Iranian family with hereditary diffuse gastric cancer.
Ghaffari SR; Rafati M; Sabokbar T; Dastan J
Eur J Surg Oncol; 2010 Jun; 36(6):559-62. PubMed ID: 20471195
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]